Of this Predictive testing is acquiring great interest as screening technique for individuals. Predictive and presymptomatic testing is utilized for the detection of gene mutations that are related to disorders appearing after birth, frequently in later stages of life. Such tests can be of assistance to individuals having a family member with a genetic disorder, though they are free of any features themselves of the disorder while testing. Predictive testing can aid in the identification of mutations that can increase an individuals possibilities of developing disorders as in the case of specific cancers.
Globally, the market for predictive & presymptomatic testing is projected to reach US$5.7 billion by 2020 and North America is set to be the highest grossing market closely followed by Europe.
2. Global Predictive and Presymptomatic Testing Market
3. Difference from conventional medical testing
3.1 Individual versus family
4. Commonly Tested Conditions
4.1 Multiple endocrine neoplasia type 2
4.3 Colorectal cancer
4.4 Breast and ovarian cancer
4.5 Alzheimer's disease
5 .Factors affecting utility
6. Possible Benefits of Predictive testing